Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-κβ pathway.
Yaiza M ArenasAndrea Cabrera-PastorNora JuciuteEloy Mora-NavarroVicente FelipoPublished in: Journal of neuroinflammation (2020)
Glycinergic neurotransmission modulates neuroinflammation. Enhanced glycinergic neurotransmission in hyperammonemia would be due to reduced extracellular cGMP. These results shed some light on possible new therapeutic target pathways for pathologies associated to neuroinflammation.